Beyond the Chart: Exploring the AI Frontier for Oncology

Matthew Ko

Beyond the Chart examines the current state of cancer care delivery and AI technology's role in oncology centers today and in a promising future. Each episode features detailed conversations with oncology leaders and clinicians, health tech innovators, and entrepreneurs driving change at the intersection of AI and oncology. Learn how intelligent tools transform clinical workflows, decision-making, and the patient experience.  Tune in for out-of-the-box thinking, real-world outcomes, and a front-row seat to the future of oncology.

單集

  1. Ep. 5: Grit, Trust, and the Human Side of AI: Leading Community Oncology Forward | Kathy Oubre, CEO of Pontchartrain Cancer Center

    10月1日

    Ep. 5: Grit, Trust, and the Human Side of AI: Leading Community Oncology Forward | Kathy Oubre, CEO of Pontchartrain Cancer Center

    Technology can actually make oncology care feel more human by restoring trust and presence between doctors and patients. In this episode, Kathy Oubre, CEO of Pontchartrain Cancer Center, shares how community oncology faces unique challenges compared to academic centers, including competition with 340B hospitals and the need for resilience and innovation. She highlights how adopting ambient AI enhanced patient care by deepening relationships and restoring trust eroded by EMRs, while also being quickly embraced by patients through transparency and clear communication. Kathy discusses both the promise of AI in areas like precision medicine, imaging, and prior authorizations, and the risks around data safety and over-reliance on automation. She closes by reframing oncology as a privilege, centered on compassion and presence during life’s most difficult moments. Tune in and learn how AI, when thoughtfully applied, can innovate cancer care while preserving its most human core Resources: Follow and connect with Kathy Oubre on LinkedIn. Follow Pontchartrain Cancer Center on LinkedIn and explore their website.

    41 分鐘
  2. Ep. 4 Part 2: Awakening Medicine’s Experimental Spirit for the Future of Oncology | Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer and Project Data Sphere

    9月10日

    Ep. 4 Part 2: Awakening Medicine’s Experimental Spirit for the Future of Oncology | Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer and Project Data Sphere

    What if ambient AI could do more than just take notes? In this episode, Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer (CEORT) and its data arm Project Data Sphere (PDS), explains why rebuilding trust after the EHR era is key to adoption, how ambient AI can move beyond documentation to enhance physician intuition, and why it’s time to rethink outdated “gold standards” like RECIST. He also discusses the role of smart policy in making biomedical data more liquid, the importance of messy real-world signals in care, and how automation could enable a rebirth of smaller, community-centered practices. Tune in to learn how AI can transform the doctor–patient relationship and accelerate better decision-making in care today! Resources: Connect with Dr. Sean Khozin on LinkedIn and visit his website. Follow the CEO Roundtable on Cancer on LinkedIn and explore their website. Learn about the Project Data Sphere here.

    39 分鐘
  3. Ep. 4 Part 1: Digital Biomarkers and the New Language of Cancer Care | Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer and Project Data Sphere

    9月3日

    Ep. 4 Part 1: Digital Biomarkers and the New Language of Cancer Care | Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer and Project Data Sphere

    What if your voice could become the next frontier in cancer care? In this first part of the 2-part episode, Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer (CEORT) and its data arm Project Data Sphere (PDS), shares how ambient AI can restore the doctor–patient bond lost to electronic health records, why voice is a powerful digital biomarker for pain, mood, and neurological changes, and how PDS is pioneering data-sharing collaborations to accelerate oncology research. He explains how open and pre-competitive platforms are enabling breakthroughs in tumor assessment, drug development, and clinical endpoints, while also reducing physician burnout and improving patient outcomes. Tune in to learn how AI and digital biomarkers are reshaping the future of cancer care! Resources: Connect with Dr. Sean Khozin on LinkedIn and visit his website. Follow the CEO Roundtable on Cancer on LinkedIn and explore their website. Learn about the Project Data Sphere here.

    36 分鐘
  4. Ep. 3 Designing for Cancer Care: AI, EHRs, and Real-World Clinical Insights | Dr. Stephen Speicher, Head of Clinical Oncology and Patient Safety, Flatiron Health

    8月11日

    Ep. 3 Designing for Cancer Care: AI, EHRs, and Real-World Clinical Insights | Dr. Stephen Speicher, Head of Clinical Oncology and Patient Safety, Flatiron Health

    The biggest breakthroughs in AI and oncology aren't just about speed, they're about bridging the gap between academic innovation and real-world care. In this episode, Dr. Stephen Speicher, Head of Clinical Oncology and Patient Safety at Flatiron Health, shares his journey from clinical practice to health tech leadership, driven by a mission to humanize care through technology. He explores how specialty-specific EHRs can address complex challenges like chemotherapy dosing and drug substitution, while highlighting the rollout of ambient AI tools to ease documentation burdens. Dr. Speicher also emphasizes the urgent need for accessible, embedded solutions in community oncology, which provides over 80% of cancer care, and discusses the real-world impact of safety, innovation, and regulatory tradeoffs. He closes with insights on building trust, bridging gaps between doctors and engineers, and turning academic advances into practical tools for frontline clinicians. Tune in and learn how AI is reducing clicks and rewriting the rules for delivering cancer care in the real world! Resources: Follow and connect with Stephen Speicher on LinkedIn. Learn more about Flatiron Health on LinkedIn and explore their website.

    47 分鐘
  5. Ep. 2 Focusing on the "Why": Technologies that Restore Purpose in Oncology | Larry Bilbrey, Director of Data Insights & Innovation, Tennessee Oncology; Senior Director of Digital Innovation, OneOncology

    8月11日

    Ep. 2 Focusing on the "Why": Technologies that Restore Purpose in Oncology | Larry Bilbrey, Director of Data Insights & Innovation, Tennessee Oncology; Senior Director of Digital Innovation, OneOncology

    AI can succeed in community oncology by delivering a clear return on investment for physician-owners while also restoring the vital human connection between doctors and patients. In this episode, Larry Bilbrey, Director of Data Insights and Innovations at Tennessee Oncology and Senior Director of Digital Innovation at OneOncology, shares the complex journey of driving AI adoption across a national network of cancer-care providers. He highlights the financial realities faced by private practices, where every technology investment is measured by its ability to generate or save money, often boiling down to the question, "Would you spend a dollar to make two or save two?" Larry examines the difficulty of scaling AI solutions across practices with vastly different sizes, resources, and levels of openness to change, from early adopters to more cautious groups. He illustrates the potential impact of AI with a real-world example of an ambient scribe that won over a skeptical physician by restoring his weekends, underscoring the powerful but often intangible return on investment in physician well-being and freeing the long-trapped potential of unstructured clinical data. Tune in and learn why tech founders must build financially accessible, vertically integrated platforms to truly meet the needs of modern oncology practices! Resources: Follow and connect with Larry Bilbrey on LinkedIn. Learn more about OneOncology on LinkedIn and explore their website. Discover more about Tennessee Oncology on LinkedIn and their website.

    50 分鐘
  6. Ep. 1 Community Oncology and the Evolving Future of Cancer Care | Dr. Gury Doshi, Medical Director, Texas Oncology; Chair, P&T, U.S. Oncology Network

    8月11日

    Ep. 1 Community Oncology and the Evolving Future of Cancer Care | Dr. Gury Doshi, Medical Director, Texas Oncology; Chair, P&T, U.S. Oncology Network

    The future of cancer care lies in the combination of cutting-edge AI and compassionate, community-based treatment. In the first episode, Dr. Gury Doshi, Medical Director at Texas Oncology and Chair, P&T at US Oncology Network, highlights how technology is transforming cancer care and clinician well-being. She explains that community oncology now delivers over 70% of treatments outside academic centers, making it essential to support innovation in these settings. Dr. Doshi discusses how ambient AI is reducing administrative burdens, helping physicians recover 3.5 hours per week, and enhancing both caregiver engagement and the quality of patient interactions. Looking ahead, she envisions AI playing a pivotal role in accelerating clinical trials, improving patient matching, and enabling more personalized, comprehensive care. Tune in and learn how ambient AI is not just relieving paperwork but quietly revolutionizing how we understand, treat, and live with cancer! Resources: Follow and connect with Dr. Gury Doshi on LinkedIn. Learn more about Texas Oncology on LinkedIn and explore their website.

    41 分鐘
  • 6 集

關於

Beyond the Chart examines the current state of cancer care delivery and AI technology's role in oncology centers today and in a promising future. Each episode features detailed conversations with oncology leaders and clinicians, health tech innovators, and entrepreneurs driving change at the intersection of AI and oncology. Learn how intelligent tools transform clinical workflows, decision-making, and the patient experience.  Tune in for out-of-the-box thinking, real-world outcomes, and a front-row seat to the future of oncology.

資料